Literature DB >> 31560920

Contribution of GABAA receptor subunits to attention and social behavior.

Tracie A Paine1, Sara Chang2, Rachel Poyle2.   

Abstract

INTRODUCTION: GABA dysfunction is associated with a number of psychiatric conditions including schizophrenia, autism and depression. Blocking cortical GABAA receptors in rodents causes behavioral deficits, including impaired attention and sociability, that are consistent with the symptoms of these conditions. The subunit composition of GABAA receptors is diverse and can affect receptor function. The current experiment examined the role of GABAA receptors containing different α-subunits in social behavior and attention.
METHODS: Male Sprague-Dawley rats were administered FG7142 (0.0-5.0 mg/kg; a non-selective GABAA receptor inverse agonist), L-655,708 (0-1.0 mg/kg; a low efficacy inverse agonist at α5-containing GABAA receptors), MRK-016 (0.0-2.0 mg/kg; a high efficacy inverse agonist at α5-containing GABAA receptors), or L-838,417 (0.0-3.0 mg/kg; an antagonist at α1-containing receptors and a partial agonist at α2, α3, α5-containing GABAA receptors) and either tested on the social interaction and social preference tests or the 5-choice serial reaction time task.
RESULTS: FG7142 decreased social interactions and impaired attention. MRK-016 impaired attention but did not affect social behavior. Neither L-655,708 nor L-838,417 significantly affected either social behavior or attention. DISCUSSION: Systemic reduction in GABAA receptor signaling decreased sociability and attention, a result consistent with past research demonstrating cortical GABAA receptor blockade impairs social behavior and attention. Overall, the effects of the receptor subtype selective ligands were minimal; α5-containing GABAA receptors may contribute to the attentional deficit but do not contribute to the decrease in sociability. Further research is needed to determine the GABAA receptor subunits that contribute to social behavior and attention.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Attention; FG7142; GABA; L-655,708; L-838,417; MRK-016; Sociability

Mesh:

Substances:

Year:  2019        PMID: 31560920      PMCID: PMC6948928          DOI: 10.1016/j.bbr.2019.112261

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  61 in total

1.  L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for alpha5-containing GABAA receptors.

Authors:  John R Atack; Peter J Bayley; Guy R Seabrook; Keith A Wafford; Ruth M McKernan; Gerard R Dawson
Journal:  Neuropharmacology       Date:  2006-10-12       Impact factor: 5.250

2.  Rapid Antidepressant Action and Restoration of Excitatory Synaptic Strength After Chronic Stress by Negative Modulators of Alpha5-Containing GABAA Receptors.

Authors:  Jonathan Fischell; Adam M Van Dyke; Mark D Kvarta; Tara A LeGates; Scott M Thompson
Journal:  Neuropsychopharmacology       Date:  2015-04-22       Impact factor: 7.853

3.  Hippocampal Neural Disinhibition Causes Attentional and Memory Deficits.

Authors:  Stephanie McGarrity; Rob Mason; Kevin C Fone; Marie Pezze; Tobias Bast
Journal:  Cereb Cortex       Date:  2017-09-01       Impact factor: 5.357

4.  Inhibition of GABA synthesis in the prefrontal cortex increases locomotor activity but does not affect attention in the 5-choice serial reaction time task.

Authors:  Samuel K Asinof; Tracie A Paine
Journal:  Neuropharmacology       Date:  2012-09-26       Impact factor: 5.250

5.  A comparison of chlordiazepoxide, bretazenil, L838,417 and zolpidem in a validated mouse Vogel conflict test.

Authors:  L Mathiasen; N R Mirza
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

6.  Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia.

Authors:  D W Volk; M C Austin; J N Pierri; A R Sampson; D A Lewis
Journal:  Arch Gen Psychiatry       Date:  2000-03

7.  Bidirectional modulation of anxiety-related and social behaviors by amygdala projections to the medial prefrontal cortex.

Authors:  A C Felix-Ortiz; A Burgos-Robles; N D Bhagat; C A Leppla; K M Tye
Journal:  Neuroscience       Date:  2015-07-21       Impact factor: 3.590

8.  Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates.

Authors:  James K Rowlett; Donna M Platt; Snjezana Lelas; John R Atack; Gerard R Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-11       Impact factor: 11.205

9.  Behavioural assays to model cognitive and affective dimensions of depression and anxiety in rats.

Authors:  M D S Lapiz-Bluhm; C O Bondi; J Doyen; G A Rodriguez; T Bédard-Arana; D A Morilak
Journal:  J Neuroendocrinol       Date:  2008-07-30       Impact factor: 3.627

10.  Decreased GABAA receptors and benzodiazepine binding sites in the anterior cingulate cortex in autism.

Authors:  A Oblak; T T Gibbs; G J Blatt
Journal:  Autism Res       Date:  2009-08       Impact factor: 5.216

View more
  2 in total

Review 1.  GABAA receptors: structure, function, pharmacology, and related disorders.

Authors:  Amr Ghit; Dina Assal; Ahmed S Al-Shami; Diaa Eldin E Hussein
Journal:  J Genet Eng Biotechnol       Date:  2021-08-21

2.  Effects of α5 GABAA receptor modulation on social interaction, memory, and neuroinflammation in a mouse model of Alzheimer's disease.

Authors:  Jovana Aranđelović; Anja Santrač; Bojan Batinić; Lidija Todorović; Vladimir Stevanović; Veera Venkata Naga Phani Babu Tiruveedhula; Dishary Sharmin; Farjana Rashid; Boban Stanojević; James M Cook; Miroslav M Savić
Journal:  CNS Neurosci Ther       Date:  2022-07-13       Impact factor: 7.035

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.